Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890821 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
A NA study of Tricuspid Regurgitation Functional, sponsored by Cardiac Implants.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT04890821 is a NA study of Tricuspid Regurgitation Functional that is actively recruiting participants, run by Cardiac Implants. The registered enrollment target is 15 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04890821, a NA study of Tricuspid Regurgitation Functional, is actively recruiting participants, sponsored by Cardiac Implants.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid regurgitation (FTR).
Conditions Studied
Interventions
- DEVICE CI Percutaneous Ring Annuloplasty System
Study Locations (2)
New Jersey
- Hackensack University Medical Center - Hackensack
New York
- Weill Cornell Medicine-New York Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-12 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04890821
The ClinicalTrials.gov registry entry for NCT04890821 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cardiac Implants, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Regurgitation Functional appearing as the primary indexed condition, and to 1 intervention - of which CI Percutaneous Ring Annuloplasty System is the first listed.
NCT04890821 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT04890821 about?
NCT04890821 is a clinical study titled "Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System". An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid...
What is the current status of trial NCT04890821?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2021-12. Estimated completion is 2027-09.
What conditions does trial NCT04890821 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation Functional.
What interventions are being tested in trial NCT04890821?
The interventions under investigation include: CI Percutaneous Ring Annuloplasty System (DEVICE).
Who is sponsoring clinical trial NCT04890821?
This trial is sponsored by Cardiac Implants, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04890821 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation Functional
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.